Is Proton Pump Inhibitor Use a Significant Confounder for Chromogranin a Levels in Sepsis?

Intensive Care Medicine - Germany
doi 10.1007/s00134-012-2664-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Relationship Between Proton-Pump Inhibitor Use and Lower Blood Magnesium Levels

International Journal of Applied Pharmaceutics
Pharmaceutical Science
2018English

Proton Pump Inhibitor Use for 12 Months Is Not Associated With Changes in Serum Magnesium Levels: A Prospective Open Label Comparative Study

Turkish Journal of Gastroenterology
Gastroenterology
2017English

Proton Pump Inhibitor Use Is Associated With a Reduced Risk of Infection With Intestinal Protozoa

Wilderness and Environmental Medicine
EnvironmentalPublic HealthOccupational HealthSports ScienceEmergency Medicine
2017English

Side Effects of Long-Term Proton Pump Inhibitor Use: A Review

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

Hypomagnesemia Associated With a Proton Pump Inhibitor

Internal Medicine
Internal MedicineMedicine
2012English

Letter: Proton Pump Inhibitor Use and Risk of Fracture

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Fundic Gland Polyposis Associated With Proton-Pump Inhibitor Use

European Journal of Case Reports in Internal Medicine
Internal Medicine
2017English

Editorial: Is Proton Pump Inhibitor Use Associated With Worse Outcomes in Patients With Liver Abscesses?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Is Prophylactic Intravenous Administration of a Proton Pump Inhibitor Necessary for Perioperative Management of Cardiac Surgery?

Heart Surgery Forum
SurgeryCardiovascular MedicineCardiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy